FDA Panel Backs Needle-Free Epinephrine for Anaphylaxis

(MedPage Today) -- FDA advisors recommended that the agency approve an intranasal epinephrine product for type I allergic reactions, including anaphylaxis, despite concerns about the lack of clinical efficacy data. On Thursday, members of the...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news